Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for M&A Research Institute Holdings, Inc. (9552:JPX), powered by AI.
M&A Research Institute Holdings, Inc. is currently trading at ¥1,064. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for M&A Research Institute Holdings, Inc. on Alpha Lenz.
M&A Research Institute Holdings, Inc.'s P/E ratio is 21.8.
“M&A Research Institute Holdings, Inc. trades at a P/E of 21.8 (fair value) with strong ROE of 39.2%. 3Y revenue CAGR of 61.9% highlights clear growth momentum.”
Ask for details →M&A Research Institute Holdings, Inc. is a specialized firm focused on providing in-depth analysis and advisory services for mergers and acquisitions. Its primary function is to conduct comprehensive research and offer strategic insights that facilitate mergers and acquisitions across various industries. The firm plays a crucial role in equipping companies with the necessary data, strategic guidance, and expert opinions needed to navigate complex M&A transactions. With its cutting-edge analytical tools and industry expertise, M&A Research Institute Holdings caters to a broad array of sectors including finance, healthcare, technology, and manufacturing. Its significance in the financial market is underscored by its ability to enhance decision-making for businesses looking to expand or consolidate through acquisition. The firm's contributions help streamline the M&A process, thereby optimizing value realization and risk management outcomes for its clients, making it an invaluable resource in the dynamic landscape of corporate finance.
“M&A Research Institute Holdings, Inc. trades at a P/E of 21.8 (fair value) with strong ROE of 39.2%. 3Y revenue CAGR of 61.9% highlights clear growth momentum.”
Ask for details →M&A Research Institute Holdings, Inc. (ticker: 9552) is a company listed on JPX in the Financial Services sector (Capital Markets). It has approximately 456 employees. Market cap is $60.0B.
The current price is 1,064 with a P/E ratio of 21.83x and P/B of 11.75x.
ROE is 39.20% and operating margin is 28.78%. Annual revenue is $16.6B.